BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20004564)

  • 1. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
    Guo L; Zhou Y; Sun Y; Zhang F
    Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.
    Guo L; Chen P; Zhou Y; Sun Y
    Exp Mol Pathol; 2010 Jun; 88(3):401-6. PubMed ID: 20206622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
    Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
    Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z by bcl-xL short hairpin RNA.
    He CW; Liu F; Zhang YF; Liang T; Zhou KY
    Ai Zheng; 2005 Jun; 24(6):646-52. PubMed ID: 15946471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.
    Gu T; Ohashi R; Cui R; Tajima K; Yoshioka M; Iwakami S; Sasaki S; Shinohara A; Matsukawa T; Kobayashi J; Inaba Y; Takahashi K
    Lung Cancer; 2009 Nov; 66(2):176-83. PubMed ID: 19285749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Etk/Bmx tyrosine kinase in the tumorigenicity of nasopharyngeal epithelium and its relation with EB virus infection and the apoptosis-related protein Bcl-2.
    Guo L; Guo Y; Xiao S
    Cancer Lett; 2006 Feb; 232(2):255-61. PubMed ID: 16458122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
    Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
    Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.
    Khodadadian M; Leroux ME; Auzenne E; Ghosh SC; Farquhar D; Evans R; Spohn W; Zou Y; Klostergaard J
    Lung Cancer; 2009 Oct; 66(1):48-57. PubMed ID: 19195736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIAPIN1 confers multidrug resistance through up-regulation of MDR-1 and Bcl-L in LoVo/Adr cells and is independent of p53.
    Zhang YF; Li XH; Shi YQ; Wu YY; Li N; He Q; Ji Q; Wang RQ; Yang SM; Fang DC
    Oncol Rep; 2011 Apr; 25(4):1091-8. PubMed ID: 21240465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase Etk/BMX protects nasopharyngeal carcinoma cells from apoptosis induced by radiation.
    Zhang Z; Zhu W; Zhang J; Guo L
    Cancer Biol Ther; 2011 Apr; 11(7):690-8. PubMed ID: 21339702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.
    Wang Q; Zeng F; Sun Y; Qiu Q; Zhang J; Huang W; Huang J; Huang X; Guo L
    Clin Cancer Res; 2018 Feb; 24(4):950-962. PubMed ID: 29208667
    [No Abstract]   [Full Text] [Related]  

  • 15. Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer.
    Zhang Y; Wang JH; Lu Q; Wang YJ
    Oncol Rep; 2012 Jan; 27(1):109-13. PubMed ID: 21971866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular models of drug- and radiation-resistant small cell lung cancer.
    Davey RA; Locke VL; Henness S; Harvie RM; Davey MW
    Anticancer Res; 2004; 24(2A):465-71. PubMed ID: 15152945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R
    Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
    Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ
    Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.